Fujifilm and HORIBA Co-Develop High-Sensitivity Inline Raman Measurement System to Advance Biopharmaceutical Manufacturing FUJIFILM Corporation and HORIBA, Ltd. have announced the joint development of a high-sensitivity inline Raman measurement system designed to provide continuous, real-time monitoring of critical manufacturing parameters…
Watchmaker Genomics Unveils New Sequencing Technologies to Improve NGS Workflow Efficiency and Data Accuracy at ESHG 2026 Watchmaker Genomics, a company recognized for its high-performance next-generation sequencing (NGS) workflow solutions, has announced the launch of two innovative technologies aimed at…
Integrated DNA Technologies Introduces End-to-End Oncology Research Workflows Optimized with Illumina, Inc. Software for Faster Insights Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics solutions, has announced a strategic collaboration with Illumina, Inc. to enhance…
Real Chemistry Delivers Double-Digit Year-Over-Year Growth in 2025 as Tier-One, Tech-Enabled Healthcare Commercialization Partner Real Chemistry today announced results for the fiscal year ending December 31, 2025, underscoring sustained momentum and reinforcing the company’s position as a commercialization partner to…
FUJIFILM Biotechnologies Unveils ShunzymeX™ Precision Purification Technology FUJIFILM Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today unveils ShunzymeX precision purification technology, which simplifies downstream processing for complex biologics. The technology will…
Quanta System Establishes U.S. Entity to Enhance Market Responsiveness and Customer Engagement Why is the U.S. market pivotal for Italian companies in the medical technology sector? Quanta System Sp.A., a leader in laser technologies for surgery, dermatology, and aesthetic medicine,…
Biotech Firm to Present at Psychedelic Therapeutics Conference in New Orleans Why are current treatments for neurodegenerative diseases often limited to symptom management? Five Discovery, a biotechnology company, is addressing this gap by developing small-molecule therapeutics to repair dysfunctional brain…
BioTalent Canada Launches Training to Help Employers Prevent and Respond to Workplace Sexual Harassment BioTalent Canada is launching online training courses to empower managers and hiring leaders to confidently prevent and address workplace sexual harassment in Canada’s bio-economy. These courses…
WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research WELL Health Technologies Corp. a technology-enabled healthcare company operating outpatient clinics that leverage scalable digital health solutions, and HEALWELL AI…
GenSight Biologics Bolsters Regulatory Leadership in US and Europe with Two Senior Appointments GenSight Biologics a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced the strategic expansion…
VB Spine Announces Intent to Acquire Exclusive Rights to Augmedics’ Spine Platform VB Spine LLC the largest privately held spine company, today announced it has entered into a definitive agreement to acquire exclusive rights to the xvision Spine System® (xvision) from Augmedics,…
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted…